anti-PD1-MDNA-109-FEAA

N/A

Report date: 2023/05/22 10:17:36

Base Information

Drug Nameanti-PD1-MDNA-109-FEAA
Drug Alias Nameanti-PD1-MDNA109FEAAanti-PD1-MDNA-109-FEAA
ClassificationBiologics
Mechanisms of ActionProgrammed cell death protein 1 blockersInterleukin-2 stimulants
TargetsInterleukin-2Programmed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedicenna Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesMedicenna Therapeutics
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A